BIVDA Press Releases

Feb 11, 2021
BIVDA Comments on Health and Care White Paper BIVDA Chief Executive Doris-Ann Williams and Chief Operating Officer Helen Dent have commented on the publication of the Health and Care White Paper by the Health Secretary Matt Hancock.  Commenting on plans to promote integrated care in the health service, Doris-Ann said; “The new White Paper offers an opportunity to promote joint working and collaboration in the NHS across different teams, department and disciplines. As part of...
Read More
Feb 04, 2021
Please see below a press release from BIVDA on the publication of the Accelerated Access Collaborative’s Our Year in Focus Report. ---  BIVDA welcomes publication of Accelerated Access Collaborative’s Our Year in Focus Report The impact that new innovations has had on the NHS is set out in the Accelerated Access Collaborative’s (AAC) report, Our Year in Focus 2019/20 which BIVDA has welcomed today. The report reveals how over 700,000 patients were provi...
Read More
Feb 03, 2021
03/02/21   CRYOcheck™ Lupus Anti-Coagulant Testing Solutions for Every Stage of the Testing Pathway For laboratories wishing to perform accurate testing for Lupus Anti-Coagulant (LA), the cryocheck™ frozen controls and reagents provide solutions to fit every stage of the pathway - screen, mix, confirm and quality control.   Available in the UK exclusively from Alpha Laboratories, these products, developed by ...
Read More
Jan 26, 2021
BIVDA Welcomes Publication of Medtech Funding Mandate  BIVDA, the UK trade association for in vitro diagnostics companies, has welcomed the publication of the Medtech Funding Mandate. In the NHS Long Term Plan, NHS England and NHS Improvement outlined how research and innovation would drive better outcomes and experience for patients. An important element of this was the commitment to introduce a MedTech Funding Mandate to accelerate the uptake of selected National Institute for Health and ...
Read More
Jan 25, 2021
25/01/2021   Simple Imaging With Results You Can Trust Now available from Alpha Laboratories, the new gelLITE gel documentation system is a compact and convenient system for documentation of agarose gels and stained protein gels.   A 302nm UV transilluminator enables imaging of large format agarose gels or stained protein gels up to 20 x 20 cm, and can slide out from the main body of the system allowing gel extraction of DNA ...
Read More
Jan 21, 2021
Cardiff, UK – 21st January 2021 – EKF Diagnostics, the global in vitro diagnostics company, announces that it has expanded into new larger manufacturing facilities at Llandough Trading Estate, Cardiff, to increase production of PrimeStore® MTM viral transport media, a key component for the COVID-19 testing regime. The new facility is over 600 sq. metres, representing a 100% increase in manufacturing area. This enables EKF to fill 36,000 PrimeStore MTM tubes daily and meet gr...
Read More
Jan 14, 2021
Member Press Release – New England Biolabs Multiplex Assay KitThis new research use only kit enables high throughput multiplex detection of SARS-CoV-2 nucleic acid, supports increased sample input and reduces background amplification from possible contaminating genomic DNA. IPSWICH, MA (January 12, 2021) — New England Biolabs® (NEB®) today announced the launch of its Luna® SARS-CoV-2 RT-qPCR Multiplex Assay Kit for real-time detection of SARS-CoV-2 nuc...
Read More
Jan 11, 2021
BIVDA Statement on UK Rare Disease Framework BIVDA Chief Executive Doris-Ann Williams has welcomed the publication of the UK Rare Diseases Framework. The Framework lists the priorities and underlying strategic themes that detail how the UK will address the challenges faced by those living with rare diseases, with four high-level priorities for action over the next five years: Helping patients get a final diagnosis faster; increasing awareness of rare diseases among healthcare professio...
Read More
Jan 07, 2021
BIVDA represents the industry sector who manufacture and distribute diagnostic tests to the NHS. These rely on a high level of automation and so industry has service engineers and technical specialists working in NHS pathology laboratories alongside NHS staff to ensure that the equipment is maintained and allowing diagnostic test results to be issued without delay.  Doris-Ann Williams, BIVDA’s Chief Executive said “This equipment will have been subjected to infected samples and ...
Read More
Dec 23, 2020
BIVDA has issued a Press Release on the MHRA's decision to grant exceptional use authorisation for NHS Test and Trace's self-testing device.  BIVDA Chief Operating Officer – Helen Dent said; “We welcome the exceptional use authorisation for this self-test device to be used as part of the wider strategy to test for and control COVID-19, but emphasise that this is part of the solution and other methods and laboratory tests remain vital. This technology has a...
Read More
Page 2 of 9 [2]